Lactic acidosis and hepatic steatosis associated with use of stavudine: report of four cases.
about
Assessment of mitochondrial toxicity in human cells treated with tenofovir: comparison with other nucleoside reverse transcriptase inhibitorsAn Increased Risk of Osteoporosis during Acquired Immunodeficiency SyndromePilot, randomized study assessing safety, tolerability and efficacy of simplified LPV/r maintenance therapy in HIV patients on the 1 PI-based regimenIn vivo assessment of mitochondrial toxicity of metacavir in Rhesus monkeys after three months of intravenous administration.Patient retention and adherence to antiretrovirals in a large antiretroviral therapy program in Nigeria: a longitudinal analysis for risk factorsUtility of serum lactate to predict drug-overdose fatality.NRTI induced mitochondrial toxicity as a mechanism for HAART related lipodystrophy: fact or fiction?Severe nucleoside-associated lactic acidosis in human immunodeficiency virus-infected patients: report of 12 cases and review of the literature.Management of chronic viral hepatitis in HIV-infected patients: Spanish Consensus Conference. October 2000.Evaluation of mitochondrial toxicity in Marmota himalayana treated with metacavir, a novel 2',3'-dideoxyguanosine prodrug for treatment of hepatitis B Virus.HIV viral suppression in the era of antiretroviral therapyCritical illness in HIV-infected patients in the era of combination antiretroviral therapy.Miller Fisher variant of Guillain-Barré syndrome associated with lactic acidosis and stavudine therapy.Clinical correlates to muscle biopsy findings in HIV patients experiencing fatigue: a case series.Mitochondrial disruption and apoptosis in lymphocytes of an HIV infected patient affected by lactic acidosis after treatment with highly active antiretroviral therapyNeuromuscular complications in HIV.Skeletal muscle involvement in human immunodeficiency virus (HIV)-infected patients in the era of highly active antiretroviral therapy (HAART).HIV Infection Is Associated with Increased Fatty Infiltration of the Thigh Muscle with Aging Independent of Fat Distribution.Lactic acidosis: from sour milk to septic shock.Growing importance of liver disease in HIV-infected persons.Hepatic steatosis is associated with fibrosis, nucleoside analogue use, and hepatitis C virus genotype 3 infection in HIV-seropositive patients.Clinical review: Respiratory failure in HIV-infected patients--a changing picture.Review article: The use of potentially hepatotoxic drugs in patients with liver disease.Hepatic steatosis associated with increased central body fat by dual-energy X-ray absorptiometry and uncontrolled HIV in HIV/hepatitis C co-infected persons.Practical guidelines for diagnosis and early management of drug-induced liver injury.HIV-related liver disease: ARV drugs, coinfection, and other risk factors.Traditional but not HIV-related factors are associated with nonalcoholic fatty liver disease in Asian patients with HIV-1 infection.Metabolic complications associated with antiretroviral therapy in HIV-infected and HIV-exposed uninfected paediatric patients.The Δ133p53 Isoform Reduces Wtp53-induced Stimulation of DNA Pol γ Activity in the Presence and Absence of D4TNucleoside reverse transcriptase inhibitor toxicity and mitochondrial DNA.The changing epidemiology of HIV-infected patients in the intensive care unit.Novel Approaches to Targeting Visceral and Hepatic Adiposities in HIV-Associated Lipodystrophy.Adverse effects of antiretroviral therapy on liver hepatocytes and endothelium in HIV patients: An ultrastructural perspective.Urine methylmalonic acid levels in HIV-infected adults with peripheral neuropathy.Symptomatic lactic acidosis in hospitalized antiretroviral-treated patients with human immunodeficiency virus infection: a report of 12 cases.Combined antiretroviral therapy causes cardiomyopathy and elevates plasma lactate in transgenic AIDS mice.Mitochondrial alterations with mitochondrial DNA depletion in the nerves of AIDS patients with peripheral neuropathy induced by 2'3'-dideoxycytidine (ddC).Longitudinal evolution of bone mineral density and bone markers in human immunodeficiency virus-infected individuals.Acquired immunodeficiency syndrome in the intensive care unit: will human immunodeficiency virus-related admissions continue to decline?The effect of long-term storage on measured plasma lactate concentrations and prospective lactate results from a multicenter trial of antiretroviral therapy.
P2860
Q24536268-B609D4C2-2D47-4651-8031-359EF4E22838Q24791238-D83454A4-79EF-4B07-88A8-104CE085E083Q28741214-93EA8299-61EC-4462-884A-FF9888CDF34DQ30885827-15814486-87D6-4ED8-9440-9C865B3B84E4Q33582279-E50429A0-EC9D-425E-B828-D17B9CA51383Q33881109-4C105A95-C559-43FE-956B-470AC228BA63Q34459416-096EE917-F57A-4515-88D3-69A486835434Q34535751-984EBA6A-A809-4330-BA56-4509EED6400EQ34614976-3E8B3550-E2F1-48DC-8517-0AE6A8CB4F4BQ34932672-4A6FAD7A-A94C-4ECA-8974-CC08030ED2C2Q35059337-933EBD66-7E3D-4D56-B8E7-F4A37DF2FAF9Q35095045-3FCD143B-75B4-4245-AF9D-1B8E76AEE389Q35127422-2E2DEB9D-F893-4061-B286-A208EBD0B26CQ35207315-210EB650-FE29-49A3-9932-7BED24ED54F3Q35586645-9D63C565-4DA4-499C-BA8A-C578B0F4262DQ35610773-56802C02-A98B-4CF0-8B5D-F591E836D296Q36132166-EA8027A5-6C4D-42A3-BF9D-A411288ECB37Q36242596-DD7251E3-8B7C-4BEA-B48C-EA0C1BC93545Q36250291-16DBF982-BA79-45B2-9F34-49393CB884ACQ36382240-830693C8-E046-4A53-9804-5C4485BF5FAAQ36521414-916A0459-15D1-4BF6-B4CA-F75498044000Q36998358-4830DEE4-A671-4CBF-845D-83DD28F5F9C6Q37232075-141F171E-6A44-4CDE-B878-1AFF1E9E3FE7Q37238258-696F4CCB-0F57-42AD-B911-9AAED5ED2334Q37341906-849A7FA4-4A6C-4856-93E0-50993952EF5FQ37391122-AE449355-2A21-4F69-82CE-3D7722764F22Q37539083-CFB0BF28-946A-404C-BF4F-8DBC1214F4CBQ37676229-9E772D72-774F-4FEB-A1B4-59458DB434EFQ37716147-08B1E9BB-EB20-44C7-9ADC-BD9B3B370045Q37798546-39B01432-9B36-431D-84B9-912DD65738B0Q37857545-A14CEEEB-8E4D-4AF3-A5C6-C881DFB1F039Q38614025-502A546A-4E86-4E12-A1EA-3AEA591AE412Q40300348-6FC8930F-806D-414D-BB36-788B96F65F4AQ42575146-A049A826-9E2E-455C-B376-B57F43ADB0E1Q43787817-D7EB74F0-8A26-4B7C-B8D3-2E087AF126B0Q43797774-F644787B-2280-42B7-854F-0CE64AC633DFQ43797776-3EE3883F-7C8D-4E2C-85FD-6761C917766AQ45729264-DFF3F0C8-86C0-464A-A5D3-0B292B6DD018Q45731497-8091CF87-315B-4E0B-9B5F-22882C4E2BF6Q46714437-B2A5A8EC-5C05-46F2-8E6F-A66D007078CE
P2860
Lactic acidosis and hepatic steatosis associated with use of stavudine: report of four cases.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh-hant
name
Lactic acidosis and hepatic st ...... avudine: report of four cases.
@en
Lactic acidosis and hepatic st ...... avudine: report of four cases.
@nl
type
label
Lactic acidosis and hepatic st ...... avudine: report of four cases.
@en
Lactic acidosis and hepatic st ...... avudine: report of four cases.
@nl
prefLabel
Lactic acidosis and hepatic st ...... avudine: report of four cases.
@en
Lactic acidosis and hepatic st ...... avudine: report of four cases.
@nl
P2093
P1476
Lactic acidosis and hepatic st ...... avudine: report of four cases.
@en
P2093
P304
P356
10.7326/0003-4819-133-3-200008010-00010
P407
P577
2000-08-01T00:00:00Z